Bristol-Myers Squibb
BMY
#193
Rank
C$166.63 B
Marketcap
C$81.60
Share price
3.85%
Change (1 day)
30.54%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): C$4.92

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is C$5.05. In 2025 the company made an earnings per share (EPS) of C$4.91 an increase over its 2024 EPS that were of C-$6.27.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.920.27%
2025C$4.91-178.28%
2024C-$6.27-213.92%
2023C$5.5030.2%
2022C$4.23-6.04%
2021C$4.50-179.29%
2020C-$5.67-281.37%
2019C$3.13-27.21%
2018C$4.30
2016C$3.79175.26%
2015C$1.38-19.83%
2014C$1.72-22.44%
2013C$2.2134.48%
2012C$1.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.39 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.96 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.86-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.92-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$40.04 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.54 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.63-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$13.26 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$5.05-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.86 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK